Stocktoria
Alpha Tau Medical Ltd. DRTS
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2022-03-08
Alpha Tau Medical Ltd. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| R&D expense | $32.1M | $27.0M | $26.4M | $20.9M | $11.4M |
| Operating income | -$42.3M | -$36.0M | -$35.7M | -$32.1M | -$13.8M |
| Income tax | $121,000 | $6,000 | $16,000 | $20,000 | $7,000 |
| Net income | -$42.6M | -$31.8M | -$29.2M | -$33.8M | -$27.3M |
| EPS (diluted) | $-0.53 | $-0.45 | $-0.42 | $-0.53 | $-0.67 |
| Operating cash flow | -$26.7M | -$19.8M | -$18.0M | -$23.9M | -$11.8M |
| Free cash flow | -$32.8M | -$22.0M | -$24.4M | -$24.8M | -$14.7M |
| Cash & equivalents | $12.2M | $13.7M | $12.7M | $5.8M | $23.2M |
| Total assets | $105.7M | $86.2M | $107.4M | $120.1M | $42.2M |
| Total liabilities | $28.6M | $23.5M | $22.9M | $14.5M | $23.0M |
| Shareholders' equity | $77.1M | $62.7M | $84.5M | $105.7M | -$34.8M |
Source: SEC EDGAR filings · CIK 0001871321 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.